Integrase Interactor 1 (INI-1) Deficient Renal Cell Carcinoma
暂无分享,去创建一个
[1] T. Zander,et al. Loss of the SWI/SNF-ATPase subunit members SMARCF1 (ARID1A), SMARCA2 (BRM), SMARCA4 (BRG1) and SMARCB1 (INI1) in oesophageal adenocarcinoma , 2020, BMC Cancer.
[2] Yukichi Tanaka,et al. Malignant rhabdoid tumour in an adult kidney: A case report. , 2019, Molecular and clinical oncology.
[3] V. Reuter,et al. Distinctive mechanisms underlie the loss of SMARCB1 protein expression in renal medullary carcinoma: morphologic and molecular analysis of 20 cases , 2019, Modern Pathology.
[4] Y. Oda,et al. Oncogenic roles of SMARCB1/INI1 and its deficient tumors , 2017, Cancer science.
[5] A. Judkins,et al. Pathology and diagnosis of SMARCB1-deficient tumors. , 2014, Cancer genetics.
[6] J. Hornick,et al. INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics , 2011, The American journal of surgical pathology.
[7] M. Tretiakova,et al. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior , 2008, Modern Pathology.
[8] D. Rakheja,et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis , 2006, Modern Pathology.
[9] J. Biegel,et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. , 1999, Cancer research.